These gluten-specific CD4 + T cells can be isolated from CD intestinal mucosa and in vitro expanded, thus representing an important source for bioassays useful to assess pathogenesis and to validate novel therapies for CD management, as reported below in more detail. The gene discussed is CD4; the disease is Cowden disease.